Get started
Author

Jing‐Ping Liou

Observed names: J. -P Liou, J. Liou, J.‐P. LIOU, Jing P. Liou, Jing Ping Liou, Jing-Ping Liou, Liou Jing-Ping, Liou, Jing-Ping
Observed institutions: Tri-Service General Hospital, National Health Research Institutes, National Taiwan University, Cheng Hsin General Hospital, Chi Mei Medical Center, National Cheng Kung University Hospital, Taipei Medical University, The Ohio State University, National Defense Medical Center, National Cheng Kung University
ORCID: 0000-0002-3775-6405
Observed ORCID: 0000-0002-3775-6405
OpenAlex ID: A5024894709
Nitro-Group-Containing Drugs
2018 · Kunal Nepali, Hsueh-Yun Lee, et al. · Journal of Medicinal Chemistry · 633
BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activityin Vivo
2004 · Ching-Chuan Kuo, Hsing-Pang Hsieh, et al. · Cancer Research · 201
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
2021 · Kunal Nepali, Jing-Ping Liou · Journal of Biomedical Science · 178
PDF
Concise Synthesis and Structure−Activity Relationships of Combretastatin A-4 Analogues, 1-Aroylindoles and 3-Aroylindoles, as Novel Classes of Potent Antitubulin Agents
2004 · Jing-Ping Liou, Yi-Ling Chang, et al. · Journal of Medicinal Chemistry · 158
Pharmaceutical Design of Antimitotic Agents Based on Combretastatins
2005 · H. Hsieh, J. Liou, et al. · Current Pharmaceutical Design · 157
Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets
2016 · Yi-Min Liu, Kunal Nepali, et al. · Journal of Medicinal Chemistry · 147
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
2022 · Amandeep Thakur, Chetna Faujdar, et al. · Journal of Medicinal Chemistry · 116
Synthesis and Structure−Activity Relationship of 2-Aminobenzophenone Derivatives as Antimitotic Agents
2002 · Jing-Ping Liou, Chun-Wei Chang, et al. · Journal of Medicinal Chemistry · 116
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma
2020 · Wen-Bin Yang, Che-Chia Hsu, et al. · Neuro-Oncology · 109
The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo
2015 · Min-Wu Chao, Mei-Jung Lai, et al. · Journal of Hematology & Oncology · 109
PDF
The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model
2018 · Sheng-Jun Fan, Fang-I Huang, et al. · Cell Death and Disease · 100
PDF
Tubulin inhibitors: a patent review
2013 · Yi-Min Liu, Hsiao-Ling Chen, et al. · Expert Opinion on Therapeutic Patents · 96
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
2013 · Yu-Hsun Kao, Jing-Ping Liou, et al. · International Journal of Cardiology · 94
Scaffold-Hopping Strategy: Synthesis and Biological Evaluation of 5,6-Fused Bicyclic Heteroaromatics To Identify Orally Bioavailable Anticancer Agents
2011 · Yen-Shih Tung, Mohane Selvaraj Coumar, et al. · Journal of Medicinal Chemistry · 94
Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach
2009 · Yu-Shan Wu, Mohane Selvaraj Coumar, et al. · Journal of Medicinal Chemistry · 91
Synthesis and Structure−Activity Relationships of 3-Aminobenzophenones as Antimitotic Agents
2004 · Jing-Ping Liou, Jang-Yang Chang, et al. · Journal of Medicinal Chemistry · 88
(N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo
2018 · Hsueh-Yun Lee, Kunal Nepali, et al. · Journal of Medicinal Chemistry · 84
Recent Update of HDAC Inhibitors in Lymphoma
2020 · I-Chung Chen, Bidyadhar Sethy, et al. · Frontiers in Cell and Developmental Biology · 83
PDF
Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
2014 · Hsueh-Yun Lee, An-Chi Tsai, et al. · Journal of Medicinal Chemistry · 80
Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
2017 · Kwang-Yu Chang, Tsung-I. Hsu, et al. · Redox Biology · 79
PDF
Antitubulin agents for the treatment of cancer – a medicinal chemistry update
2006 · Neeraj Mahindroo, Jing-Ping Liou, et al. · Expert Opinion on Therapeutic Patents · 79
Discovery of 4-Amino and 4-Hydroxy-1-aroylindoles as Potent Tubulin Polymerization Inhibitors
2008 · Jing-Ping Liou, Zi-Yi Wu, et al. · Journal of Medicinal Chemistry · 77
5-Amino-2-Aroylquinolines as Highly Potent Tubulin Polymerization Inhibitors
2010 · Chih-Ying Nien, Yun-Ching Chen, et al. · Journal of Medicinal Chemistry · 76
7-Aroyl-aminoindoline-1-sulfonamides as a Novel Class of Potent Antitubulin Agents
2006 · Jang-Yang Chang, Hsing-Pang Hsieh, et al. · Journal of Medicinal Chemistry · 75
5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes
2018 · Hsueh-Yun Lee, Sheng-Jun Fan, et al. · Journal of Medicinal Chemistry · 71
Works count: 278
Citation count: 6,842
H-index: 44
I10-index: 144
Year
Topic
Type